Solid State Heterogeneous Biocatalysts

A Novel Approach to Wound Care and Skin Health

floating_hand

Everyone will experience a wound or skin challenge in their lifetime.

We all deserve the peace of mind knowing we will heal.

NanoSALV Catalytic Advanced Wound Care Treatment Matrix

A Canadian made, award winning, Health Canada approved medical device. This technology has been used to increase the speed of healing wounds, from small skin tears to chronic wounds, to a wide range of dermatological challenges.
NanoSALV_trio_no_background
Icons-01
Improved wound healing by

~57.6%¹

Icons-03
Reduced wound care costs by

~46%²

Icons-02
Improved mental health and quality of life for patients and healthcare staff

Achieving Patient, Economic, & Operational Benefits through Patented Catalytic Technology

Catalysts make reactions happen better and faster. NanoSALV’s unique catalytic technology optimizes natural wound healing, resulting in better and faster healing outcomes.

Indications

NanoSALV’s simple design makes it easy to apply to a variety of wound types, shapes, and sizes, including early-stage intervention, surgical wounds, chronic-stage wounds, and a variety of dermatological challenges. 
Health Canada has approved this product as a medical device with the following claims:
  • Actively Supports and Promotes Wound Healing

  • Reduces Inflammation

  • Broad-Spectrum Antimicrobial Effect within the Protective Matrix Barrier

NanoTess in the News

Contact Our Partner Success Team

Studies, resources, and clinical peer references are available to assist in the integration of NanoSALV Catalytic within your health care organization. Contact our partner success team for more information.

Canadian Made, Globally Compassionate

NanoSALV’s simple design makes it easy to apply to a variety of wound types, shapes, and sizes, including early-stage intervention, surgical wounds, chronic-stage wounds, and a variety of dermatological challenges. 
Screenshot_2024-04-17_154800
Our Community & Supporters:
logo-grrit-nanotess
logo-alberta-innovates-nanotess
logo-creative-destruction-lab-nanotess
logo-bio-alberta-nanotess
logo-thin-air-labs-nanotess
logo-aventrock-nanotess
logo-cels-nanotess
¹ W21C Research and Innovation. Centre Act to Improve Pressure Injuries in Alberta: Feasibility of Using NanoSALV Catalytic Advanced Wound Care Treatment Matrix to Treat Pressure Injuries and Chronic Wounds. 2023
² Institute of Health Economics, Executive Summary - Trial-based Economic Evaluation for the NanoSALV Catalytic Advanced Wound Care Treatment Matrix for the Management of Pressure Injuries, Diabetic Foot Ulcers, and Leg Ulcers, Table 5. Nov 2023.